Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
2 results
Filters applied: . Clear all
Page 1
Discontinuation of BRAF/MEK-Directed Targeted Therapy after Complete Remission of Metastatic Melanoma-A Retrospective Multicenter ADOReg Study.
Cancers (Basel). 2021 May 12;13(10):2312. doi: 10.3390/cancers13102312.
Cancers (Basel). 2021.
PMID: 34065877
Free PMC article.
Anticoagulation with Factor Xa Inhibitors Is Associated with Improved Overall Response and Progression-Free Survival in Patients with Metastatic Malignant Melanoma Receiving Immune Checkpoint Inhibitors-A Retrospective, Real-World Cohort Study.
Haist M, Stege H, Pemler S, Heinz J, Fleischer MI, Graf C, Ruf W, Loquai C, Grabbe S.
Haist M, et al.
Cancers (Basel). 2021 Oct 12;13(20):5103. doi: 10.3390/cancers13205103.
Cancers (Basel). 2021.
PMID: 34680252
Free PMC article.
Item in Clipboard
Cite
Cite